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ABSTRACT 
Geriatric patients have more comorbidities and often receive polypharmacy prescriptions. The 
prevalence of inappropriate drug use in geriatric patients is in the range of 11.5% - 62.5%. The 
consequence of polypharmacy is Adverse Drug Reactions (ADR). An effort to reduce the occurrence of 
medication errors in geriatric patients is the STOPP and START criteria. This study aimed to identify PIMs 
(Potentially Inappropriate Medications) and PPO (Potentially Prescribing Omission) in geriatric patients 
according to STOPP / START criteria at Gatot Soebroto Army Hospital and the Jakarta Cempaka Putih 
Islamic Hospital. This study used a descriptive-analytical method with a cross-sectional design and a 
prospective data collection method based on analysis of medical records, inpatient installation, and 
pharmacy installation at Gatot Soebroto Army Hospital in Jakarta on October 2017 and Jakarta Cempaka 
Putih Islamic Hospital in January 2019. The tool used to collect data in this research was the STOPP START 
toolkit supporting medication review version 1 2016. The results show that of 85 hospitalized geriatric 
patients at Gatot Soebroto Army Hospital with the use of 579 drugs, PIMs were present in 8.24% of 
patients and the prevalence of PPO was 5.88%. Meanwhile, out of 124 hospitalized geriatric patients in 
Jakarta Cempaka Putih Islamic Hospital with the use of 945 drugs, PIMs were present in 35.48% of patients 
and the prevalence of PPO was 6.45%. Polypharmacy found to be an independent predictor for PIMs 
incident. 
Keywords: geriatrics; PIMs; PPO; STOPP/START criteria 
 
INTRODUCTION 
There is an increase in the number of 
population of persons age 65 years and older 
nowadays1 It has been estimated that the 
proportion of the world's population over 60 
years will nearly double from 12% in 2015 to 
22% in 20502. Geriatric patients are elderly 
patients with multiple diseases and/or 
disorders due to decreased organ, 
psychological, social, economic and 
environmental functions that require 
integrated health services with a 
multidisciplinary approach3. In Indonesia, the 
morbidity rate for the elderly was 28.62% in 
2015, meaning that out of every 100 elderly 
people there were around 28 people who were 
ill4. 
Geriatric-related physiological changes 
cause pharmacokinetic and 
pharmacodynamic changes in drugs in 
geriatric patients. Geriatric patients have more 
comorbidities and often receive polypharmacy 
prescriptions. Polypharmacy refers to the use 
of several drugs, five or more types. Recently, 
polypharmacy is used to describe PIP 
(Potentially Inappropriate Prescribing) or the 
use of drugs that are not quite right. The 
prevalence of inappropriate use of drugs in 
geriatric patients is in the range of 11.5% -
62.5%. The consequence of polypharmacy is 
Adverse Drug Reactions5.  
One effort to reduce the occurrence of 
medication errors in geriatric patients involves 
the use of a standard list of drugs classified 
according to the risks and benefits generated, 
aimed at guiding doctors when choosing 
treatment for patients, including the Beers and 
STOPP and START criteria methods. The 
STOPP criteria (screening tool for geriatric 
prescription) and START (screening tool to 
remind doctors of appropriate prescription) 
were created in 2003 to overcome possible 
deficiencies of the Beers criteria. These criteria 
comprise potentially unsuitable drugs 
Potentially Inappropriate Medications (PIMs) 
explained by STOPP, and potential omissions 
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for prescription Potential Prescribing 
Omissions (PPO), explained by START. This 
START method is intended to increase 
treatment success in geriatric patients6,7.  
In one study, it was found that 22% of 
geriatric patients met the STOPP / START 
criteria8. Another study conducted in Turkey 
found 14.8% of inappropriate drug use 
according to STOPP criteria9. Research data in 
Indonesia include research conducted in 
Yogyakarta. From this study, 17% of patients 
with chronic kidney disease obtained an 
average of one PIMs, while 38.9% of patients 
with osteoarthritis obtained an average of one 
PIMs10,11 
The results of the identification of PIMs 
with the STOPP and START screening tool 
have not been well documented in Indonesia, 
especially in hospitals in Jakarta. The 
researcher found the necessary to assess PIMs 
and PPO based on STOPP and START criteria 
to reduce the incidence of Adverse Drug 
Reactions (ADR). 
The increasing number of geriatrics 
both in Indonesia and in the world will 
increase the need for health. Previous research 
data states that there is an increase in ADR        
in the elderly, so the use of drugs in the     
elderly should continue to be evaluated              
to improve patient clinical outcomes.              
This evaluation is expected to be a standard or 
guideline for hospitals in the treatment of 
geriatric patients. 
The objective of this research is to obtain 
information about the patient characteristics, 
find out and identify Potentially Inappropriate 
Medications (PIMs) and Potentially 
Prescribing Omission (PPO) in geriatric 
patients according to STOPP / START criteria 
at Gatot Soebroto Army Hospital and Jakarta 
Cempaka Putih Islamic Hospital, and also to 
find the correlation between patient 
characteristics and PIMs. The research used 
the tools which is already used worldwide. 
The differences between this research and 
another similar researches that had been 
conducted in Jakarta were the prospective 
method and the greater number of samples. 
The data obtained is expected to be used            
as guidelines/treatment guidelines for 




The tool used to collect data in this 
research was the STOPP START toolkit 
supporting medication review version 1 2016. 
 
Methods 
This research was descriptive with 
prospective data collection methods using 
STOPP START toolkit supporting medication 
review version 1 2016. The population of this 
study is all geriatric inpatients at Gatot 
Soebroto Army Hospital in October 2017 and 
Jakarta Cempaka Putih Islamic Hospital 
January 2019 period.  The reason for using 2 
different time periods is inadequate data in 
2017 and further research can only be carried 
out in early 2019. The samples of this study 
were all geriatric inpatient at Gatot Soebroto 
Army Hospital in October 2017 and Jakarta 
Cempaka Putih Islamic Hospital in January 
2019 that met the following inclusion criteria 
and exclusion criteria: 
Inclusion criteria: patients aged ≥ 60 
years, patients had complete medical record 
data, including age, sex, diagnosis, drug use, 
and laboratory data (hematological 
examination such as, hematocrit, hemoglobin, 
erythrocytes, and leukocytes; examination of 
electrolyte levels, glucose levels, blood gas 
analysis, and uric acid levels; examination of 
kidney function such as creatinine and 
creatinine clearance urinalysis including, pH, 
urine color; liver function tests; lipid 
examination such as, Low Density Lipoprotein 
(LDL), High Density Lipoprotein (HDL), and 
triglycerides). 
Exclusion criteria: geriatric patients 
were hospitalized at the Gatot Soebroto Army 
Hospital and Jakarta Cempaka Putih Islamic 
Hospital which had not been discharged after 
the research schedule and patients who had 
died. 
The research proposal was submitted to 
the Ethics Committee of Faculty of Medicine, 
University of Indonesia. This study had 
received the Ethical Approval test and             
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was declared to pass the study ethics study 
with the protocol number 18-09-1142. The 
patient screening was done after the research 
permit was obtained. Research procedure: 
submission of a request for a research permit 
to the hospital and ethical approval (ethical 
review) to the ethics committee. The minimum 
sample size was not specified, the sampling 
method used was total sampling, that was all 
respondents who are meet the inclusion 
criteria. Data were obtained from medical 
records, inpatient installation, and pharmacy 
installation. The study took place 
prospectively for 1 month. Screening of the 
accuracy of treatment prescribed for      
inpatient geriatric patients. The data obtained 




Data were analyzed descriptively to 
obtain a frequency distribution as well as the 
proportion of the variable of the study.            
The variable was patient characteristic.                   
Data were  also  assessed   for   PIMs  and   PPO.  
STOPP START toolkit supporting medication 
review version 1 2016 contains a list of drugs 
which consider into the STOPP category 
(hereinafter referred to as PIMs), which means 
the use of these drugs on geriatrics needs to be 
stopped. Besides, the toolkit also contains a list 
of drugs that needs to be initiated (hereinafter 
referred to as PPO), which consider into the 
START category, which means a continuation 
of recommendations from drugs that were 
previously recommended to be stopped due to 
the PIMs incidence from STOPP. 
From the samples obtained, it will be 
determined the proportion of the samples 
identified to have PIMs as well as what drugs 
have the most PIMs. Then from each drug that 
is included in STOPP, also listed alternative 
treatment (START) recommendation. 
Pearson's chi-squared test was performed to 
determine the correlation between patient 
characteristic and PIMs. Statistical significance 
was set at p<0.05. All statistical analysis was 
performed using the Statistical Package for 
Social Sciences software for Windows version 
16.0. 
 
RESULTS AND DISCUSSION 
As many as 85 patients were selected as 
respondents from Gatot Soebroto Army 
Hospital during October 2017  and 124 
patients from Jakarta Cempaka Putih Islamic 
Hospital during January 2019. 
 
Patient characteristics 
Distribution of patients based on patient 
characteristics was shown in table I. Female 
was the major respondents (52.94% at Gatot 
Soebroto Army Hospital and 59.68% at Jakarta 
Cempaka Putih Islamic Hospital). This result 
is related to the data of the elderly population 
in Indonesia in 2017 which states that the 
number of elderly women is higher at 9.53% 
compared to elderly men at 8.54%4. The 
majority of respondents aged 60-74 years 
(74.12% at Gatot Soebroto Army Hospital and 
72.58% at Jakarta Cempaka Putih Islamic 
Hospital). According to a report,  the number 
of elderly is growing fast. In 2017, the 
population aged 60-79 is higher than the 
population aged > 80 years. The number of 
older people over 80 years has also increased. 
World population aged 80 years or more is 
expected to increase 3-fold between 2017 and 
2050, increasing from 137 million to 425 
million12.  
The respondents mostly used 5-10 
medicines at Gatot Soebroto Army Hospital 
(67.06%) as well as at Jakarta Cempaka Putih 
Islamic Hospital (65.32%). Pharmacokinetic 
changes will occur in line with ageing. 
Therefore it is necessary to adjust the dose to 
avoid the occurrence of ADR. The risk of ADR 
events generally arises due to polypharmacy, 
especially in geriatrics13 and this risk will 
increase with age, comorbidity, and the 
number of drugs consumed14. Other risk 
factors associated with polypharmacy are 
DRP, such as unwanted side effects (ADEs), 
low compliance with drug use, drug-drug 
interactions, drug-disease interactions,           
and   high   risk   of   the   geriatric    syndrome15.                  
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The amount of the risk of the possibility of 
drug interactions in elderly patients who get 5-
9 drugs reaches 50%, while the risk can 
increase up to 100% for patients who get more 
than 20 drugs16. A retrospective study on 
evaluating geriatric inpatient events found 
that patients who received more than five 
drugs had almost 4 times the risk of 
hospitalization due to ADEs17. Other studies 
stated an increase in the incidence of ADEs 
that is higher in the elderly than other ages in 
recent years from 32.7 to 48.8 events with a 
ratio of 1 in 20 patients18. Thus, it can be stated 
that there is a significant relationship between 
the increasing number of drugs used with 
PIMs. 
 
Potentially Inappropriate Medication (PIMs) 
and Potentially Prescribing Omission (PPO) 
Based on the STOPP criteria, from 85 
geriatric patients at Gatot Soebroto Army 
Hospital with 579 drugs used, PIMS was 
present in 8.24% of patients with 7 PIMS 
events, while of 124 patients at Jakarta 
Cempaka Putih Islamic Hospital with a total of 
945 drugs, PIMs were present in 35.48% of 
patients with 44 PIMS events (Table II). While 
based on START criteria, out of a total of 579 
Table I. Patient Characteristic 
 





































































Total 124 100 
*Age is based on WHO classification 
 






Gatot Soebroto Army Hospital PIMs 7 8.24 
PPO 5 5.88 
Total 12  
Jakarta Cempaka Putih Islamic 
Hospital 
PIMs 44 35.48 
 PPO 8 6.45 
Total 52  
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drugs used by geriatric patients at Gatot 
Soebroto Army Hospital, the prevalence of 
PPO was 5.88%. with 5 PPO events and the 
prevalence of PPO was 6.45% with 8 PPO 
events obtained from 945 drug use at geriatric 
patients at Jakarta Cempaka Putih Islamic 
Hospital. The results of this study are higher 
when compared to studies conducted by 
Blanco-Reina et al., (2016) that PIMs were 
present in 18.7% of patients. The prevalence of 
PPOs was 34.7%, which is higher than this 
study. A similar data with this study stated 
that the prevalence of PIMs were 43.5% and 
40.2% respectively and the prevalence of PPO 
were 52.8% and 53.9% respectively20.    
 
Potentially Inappropriate Medication (PIMs) 
According to STOPP START toolkit 
supporting medication review version 1 2016, 
the most common PIMs which found in both 
hospitals were the combination use of 
aldosterone antagonist and ACEIs or AIIRA 
(42.86% at Gatot Seobroto Army Hospital and 
27.27% at Jakarta Cempaka Putih Islamic 
Hospital), as seen on table III. The use of a 
combination of aldosterone antagonists with 
ACEI or ARB were 12 incidents at Jakarta 
Cempaka Putih Islamic Hospital and 3 at Gatot 
Soebroto Army Hospital. These drugs are 
usually used as antihypertensive therapy 
which will pose a risk of side effects of 
hyperkalemia when given in a combination. 
Symptoms that appear and are very 
dangerous, especially for geriatrics are 
bradyarrhythmia, and sudden collapse21.      
The most commonly used combination in this 
study is spironolactone with candesartan. 
The highest number of PIMs were 
Anticholinergic Drug Burden (ACB score) of 
29.55% in patients at Jakarta Cempaka Putih 
Islamic Hospital. This scale aims to assess the 
anticholinergic effect by adding up drugs with 
anticholinergic effect obtained by the patient. 
The measurement of Anticholinergic Drug 
Burden is divided into several categories, they 
are no anticholinergic activity (value = 0), 
possible anticholinergic activity (value = 1), 
definite anticholinergic activity (value = 2         
or 3)22. In this study, of 124 patients, 99 patients 
received drugs with anticholinergic activity 
and 13 of them included PIMs because               
the total ACB score was ≥4, while the rest had 
a total score <4. Drugs with anticholinergic 
activity most often used in this study       
include alprazolam, ranitidine, furosemide,                   
and betahistine.  
Anticholinergic drug prescriptions are 
usually given for diseases such as depression, 
parkinsonism, urinary incontinence, peptic 
ulcer, and allergies23. One study reported that 
the majority of the geriatric population would 
get at least one type of anticholinergic drug22. 
High-dose anticholinergics with ACB score ≥4 
have side effects on nerve disorders, such as 
delirium, seizures, anxiety, hallucinations,    
and dementia24. It also can reduce cognitive 
function in geriatrics. However, these side 
effects are difficult to detect in geriatrics 
because they are often linked as natural causes 
that arise during the ageing process23. 
Research conducted in a systematic review 
showed that of 27 studies only 2 of them did 
not have an association between 
anticholinergic use with decreased cognitive 
function both acute (delirium) and chronic 
(dementia)25.  
 
Potentially Prescribing Omission (PPO) 
Based on table IV, the most identified 
PPO was the absence of an inhaled 
corticosteroid drug given to asthma or 
moderate-severe COPD patients by 75% in 
geriatric patients at Jakarta Cempaka Putih 
Islamic Hospital. The significant number of 
older asthmatics who are poorly controlled 
leads to increased morbidity and mortality 
rate. On the other hand, a clear guidance on 
asthma management in geriatric asthma 
patient is minimum. Many geriatric patients 
who were admitted to emergency 
departments for asthma condition were not 
using ICS26. This evidence proves the need for 
inhaled corticosteroid in the elderly.                    
At the Gatot Soebroto Army Hospital,               
the highest PPO (60%) was the absence of or 
AIIRA (if patient intolerant with ACEI) in 
diabetes with evidence of renal 
impairment/disease. Based on the evidence, 
Daniek Viviandhari, et al 
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the provision of combination therapy with 
ACE Inhibitors or AIIRA could inhibit the 
development of renal disease1. 
 
Correlations between Patient Characteristics 
and PIMs 
Based on Pearson's chi-squared test in 
table V, there was no statistically significant 
association between sex or age and PIMs in 
both hospitals. This is supported by research 
which states that age, sex, multiple diseases, 
and the use of ≤4 medications was not related 
to PIMs prescription27. Meanwhile, the results 
of the correlation test between the number of 
drugs with the incidence of PIMs in geriatric 
patients showed a significant relationship        
(p-value = 0.013) in patients at Jakarta 
Cempaka Putih Islamic Hospital. 
Polypharmacy was an independent predictor 
of PIMs.  
There are some efforts that can be done 
to prevent the incidence of PIMs in both 
hospitals, considering the conditions of both 
hospitals. The first attempt is to use the STOPP 
Table III. List of PIMs 
 
Location PIMs criteria n % 
Gatot Soebroto 
Army Hospital 
Aldosterone antagonists co-prescribed with ACEIs or 
AIIRA  
3 42.86 
NSAID on moderate-severe heart failure patient 1 14.28 
Aspirin co-prescribed with clopidogrel as a secondary 
stroke prevention 
1 14.28 
Thiazide diuretic in  significant hypokalaemia patient 1 14.28 
Loop diuretic as a single therapy for hypertension 1 14.28 





Concomitant use of two or more drugs with potential 
for anticholinergic adverse effects (Anticholinergic 
Drug Burden /ACB) 
13 29.55 
Aldosterone antagonists co-prescribed with ACEIs or 
AIIRA 
12 27.27 
 Sulfonylureas with a long duration of action with type 
2 diabetes mellitus  
3 6.82 
 Centrally-acting antihypertensives use on elderly 3 6.82 
 NSAID with severe or uncontrolled hypertension  2 4.55 
 Diuretics which increase urinary flow with concurrent 
urinary incontinence 
2 4.55 
 Alpha1-receptor blocker in those with symptomatic 
orthostatic hypotension 
2 4.55 
 Domperidone in patients with serious heart conditions 1 2.27 
 ACEIs or AIIRA in patients with hyperkalaemia 1 2.27 
 Amiodarone as first-line therapy for arrhythmia in 
supraventricular tachyarrhythmias 
1 2.27 
 Benzodiazepines on patient who had fallen in the past 
3 months 
1 2.27 
 Loop diuretic as a single therapy for hypertension 1 2.27 
 Loperamide on patient with blood and mucus in the 
stools   
1 2.27 
 Verapamil with heart failure 1 2.27 
 Total 44 100 
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and START criteria or to make another 
standard or guideline specialized on each 
hospital to guide doctors when choosing 
treatment for patients, this also require some 
laboratory data needed to make sure that the 
treatment given is suitable for patients, 
including for PPO. The second one is to 
strengthen pharmacist role on screening the 
patient’s prescription. Pharmacist should be 
alert when patients get more than 5 drugs, 
since there is a significant relationship 
between the increasing number of drugs     
used with PIMs. Pharmacist should also            
be aware when patients prescribed with        
drugs with anticholinergic activity.                  
This study still has many limitations.                   
As only 2 hospitals were involved in this 
study, result generalization for the     




The prevalence of PIMs in the study was 
considerably moderate (8.24% and 35.48%) 
while the prevalence of PPO was 5.88% and 
6.45%, respectively. There is a significant 
correlation between the number of drugs with 
the incidence of PIMs. Health care 
professionals are expected to be able to review 
medication prescribed for geriatric patients 
Table IV. List of PPO 
 





ACEI or AIIRA (if intolerant of ACEI) in diabetes patient 
with evidence of renal disease 
3 60 
Appropriate beta-blocker with stable systolic heart failure.    1 20 
Regular inhaled Beta-2 agonist for mild to moderate 
COPD.  
1 20 





Regular inhaled corticosteroid for moderate-severe 
asthma or COPD 
6 75 
ACEI or AIIRA (if intolerant of ACEI) in diabetes with 
evidence of renal disease 
1 12.5 
Vitamin D and calcium (where dietary calcium intake 
inadequate) supplement in patients with known 
osteoporosis 
1 12.5 
 Total 8 100 
 
Table V. Correlation between Patient Characteristics and PIMs 
 
Location Correlation P-value 
Gatot Soebroto Army Hospital Sex*PIMs 
Age*PIMs 
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using new guidelines so that the incidence of 
PIM can be prevented. 
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